Nasdaq
$0.2376▼ 25.75%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.1MShares out 4.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 2d agoPre-market26.10.23 10:45filedS-8 POSOffering#●●●
Lunai Bioworks Inc.
Lunai Bioworks Inc. has deregistered 7,181,694 unsold shares previously registered under its 2019 and 2014 equity incentive plans. The company has terminated all offerings of these securities and filed this post-effective amendment to remove all remaining unsold shares from registration.…more
$0.2376-25.75%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 2d agoPre-market26.10.23 10:44filedPOS AMOther
Lunai Bioworks Inc.
Lunai Bioworks Inc. has filed a Post-Effective Amendment to terminate all offerings under its existing S-3 registration statement and deregister all unsold securities. Following the termination of its ATM Sales Agreement with Dawson James Securities on October 16, 2026, no further securities will be offered or sold under this registration statement.…more
$0.2376-25.75%vs prev closeView filingShare - 2d agoPre-market26.10.23 10:43filedS-8 POSOffering
Lunai Bioworks Inc.
Lunai Bioworks Inc. has filed a post-effective amendment to deregister all unsold shares previously registered under its 2023 Equity Incentive Plan (Form S-8). Consequently, all offerings and sales of securities under this registration statement are terminated effective immediately.…more
$0.2376-25.75%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoOvernight26.10.23 16:08Bullish#●●●
Lunai Bioworks Faces Nasdaq Delisting, Will Voluntarily Deregister
Lunai Bioworks received a delisting determination from Nasdaq due to failing to meet the $2.5 million equity requirement. The company will not request a hearing and plans to voluntarily delist and deregister its shares.…more
$0.2376-25.75%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.9Regular26.10.10 03:22
●●●●●●●● ●●●●● ●●●●●●
Lunai Bioworks has requested an immediate trading suspension from Nasdaq, citing concerns over alleged illegal short selling and failures to deliver. The company is currently involved in litigation and seeks regulatory assessment to protect its investors.…more
$0.2376-25.75%vs prev closeShareBenzinga - 9.29After-hours26.09.30 05:55
●●●●●●●● ●●●●● ●●●●●●
Lunai Bioworks announced a delay in filing its annual report with the SEC and expects a net loss of approximately $3.2 million for fiscal year 2026. While the loss is significantly lower than the previous year, the improvement is primarily driven by one-time accounting adjustments and restructuring rather than operational growth.…more
$0.2376-25.75%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report